Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.55%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 1.29Close
$ 1.06 - $ 2.55 52-Week Range
Ticker Information
Ticker
HRTXCompany Name
HERON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQHERON THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
HRTX - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 2.32M | 1.55% | $ 149.69M |
| 3/31/2025 | $ 2.35M | 1.58% | $ 148.52M |
| 12/31/2024 | $ 2.49M | 1.73% | $ 144.28M |
| 9/30/2024 | $ 2.63M | 1.91% | $ 137.74M |
| 6/30/2024 | $ 2.77M | 2.03% | $ 136.36M |
| 3/31/2024 | $ 2.87M | 2.17% | $ 132.1M |
| 12/31/2023 | $ 2.9M | 2.28% | $ 127.04M |
| 9/30/2023 | $ 2.98M | 2.42% | $ 122.84M |
| 6/30/2023 | $ 2.95M | 2.5% | $ 117.96M |
| 3/31/2023 | $ 2.89M | 2.54% | $ 113.83M |
Key Performance Insights, Last 5 Years
- HERON THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 2.62%.
- Over the past 5 years, HERON THERAPEUTICS INC's average DepAmor % has been 2.63%.
- The median DepAmor % for HERON THERAPEUTICS INC during this period was 2.58%
- HERON THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 3.56%.
- The lowest DepAmor % recorded by HERON THERAPEUTICS INC in the same timeframe 1.55%
HERON THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for HERON THERAPEUTICS INC is calculated as follows: DepAmor [ $ 2.7M ] / Revenues [ $ 103.12M ]
(=) DepAmor % [ 2.62% ] HRTX - Depreciation and Amortization Margin, Last 5 years
1.55%
Minimum
Jun 30, 2025
3.56%
Maximum
Mar 31, 2021
2.63%
Average
2.58%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |